Toggle Offcanvas
...
 
Guselkumab Tenders

Guselkumab Tenders

View Guselkumab tenders, RFPs and contracts. Bid on readily available Guselkumab tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Guselkumab tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Guselkumab.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Guselkumab market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Guselkumab tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

15 Live Notices for Guselkumab Tenders

Showing 1 to 15

Immunopreparaty 2025
country Czech Republic
posting date07 Mar 2025
deadline09 Apr 2025
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date25 Feb 2025
deadline05 Mar 2027
Successive Delivery Of Medicines For The Center Of Rheumatology Sp. Z O.O. - Order No. 2.
country Poland
posting date15 Feb 2025
deadline21 Mar 2025
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab
country Germany
posting date09 Dec 2024
deadline10 Nov 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Guselkumab (L04Ac16) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date06 Nov 2024
deadline31 Oct 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Guselkumab (L04Ac16) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date06 Nov 2024
deadline31 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum W.
country Germany
posting date17 Oct 2024
deadline05 Oct 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab (Only In The Strength 100 Mg), (Obo), Atc L04Ac16 For The Period 01.12.2024 - 30.11.2026
country Germany
posting date16 Oct 2024
deadline05 Oct 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab (Only In The Strength 100 Mg), (Obo), Atc L04Ac16 For The Period 01.12.2024 - 30.11.2026
country Germany
posting date16 Oct 2024
deadline05 Oct 2026
Medicines Containing The Active Substance Guselkumab (Atc: L04Ac16)
country Germany
posting date22 Jun 2024
deadline31 May 2026

Share Share this page